Adverse drug reactions in neonates: a brief analysis of the FDA adverse event reporting system

IntroductionDrug trials in neonates are scarce, and the neonates may consequently be at risk of adverse drug reactions (ADRs). Spontaneous ADR reporting is an important tool for expanding the knowledge on drug safety in neonates. This study explores the quality of current neonatal ADR reports and th...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Pernille Kähler Byskov, Christoffer Storm Baden, Jon Trærup Andersen, Espen Jimenez-Solem, Ramus Huan Olsen, Christina Gade, Ulrik Lausten-Thomsen
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Frontiers Media S.A. 2024-06-01
Σειρά:	Frontiers in Pharmacology
Θέματα:	pharmacology adverse drug events neonatal pharmacology public health pharmacovigilance
Διαθέσιμο Online:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1395982/full
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!